Foresite 360 is designed to screen approximately 350 genes, out of 22,000. We sequence all 22,000 as new discoveries are made constantly by the research community associating the other 20,000+ genes with disease. By sequencing once and re-analyzing often we can provided updated reporting to incorporate these new insights

Yes! Genetic conditions are often more easily managed when planned for before symptoms appear. By screening your newborn, we can give you the tools to provide proactive healthcare, increasing their quality of life and minimising their symptoms.

For example, symptoms of a condition like spinal muscular atrophy are shown to be greatly reduced when treatment begins prior to the onset of symptoms. Alternatively, detecting a high risk of, for instance, childhood cancer can prompt regular, preemptive screening to catch it early (should it develop).

Many potential conditions, diseases and disorders could be found with whole genome screening, including childhood cancers, cardiovascular conditions, endocrine conditions, hepatic conditions, immunodeficiencies, pulmonary disorders, hematologic disorders, metabolic disorders, neurological conditions, renal conditions, skeletal disorders and more. Foresite only reports for diseases that can be proactively managed and provides support through Genetic Counselors to help navigate any findings

Fore’s “sequence everything” approach—which assesses 22,000 genes and all 3.3 billion base pairs—is the reason we are able to provide lifelong genetic health support to your child. It means we can safely store their entire genome, re-evaluating it as genetic science progresses and more treatments are developed. In doing this, we can ensure your child receives the best possible support, the most up-to-date treatment and the most relevant advice as they grow up.

Alternative genome sequencing methods, such as targeted panel gene sequencing, lack the long-term applications that come from whole genome sequencing. With the number of genomes sequenced planned to grow exponentially (approximately 1.5 million currently as compared to a forecasted 13.5 million), the benefit of taking an all-encompassing model of a person’s genetic code is truly staggering.

By working with Fore to safeguard your child’s health, you’ll be benefitting from the latest advances of the ever-expanding, multi-billion dollar human genetics industry.

Fore is based in San Diego, CA. All samples are processed in US-based CLIA-compliant and CAP certified labs ensuring the highest quality of data generation.

Because of the complex nature of sequencing and custom analysis, it usually takes 6-8 weeks for Fore to return the initial clinical report. During that time, you will be able to access Fore’s platform to complete your profile to help make future re-analysis more personalized.

Fore stores all data in a secure, HIPAA & HITECH compliant using a custom built cloud architecture designed for genomics. All data is de-identified according to the standard for de-identification provided by HIPAA Privacy Rule.

No! Fore will never sell data or store data outside of the USA.